Pyxus International, Inc. PYYX OTC · Consumer defensive · United States
$2.27 -5.42% -$0.13
Summary
55 / 100 · Bulios Score
What speaks for it
- Revenue grew by 8.0% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Operating profit does not even cover the interest on its debt.
- Out of every 100 USD of revenue, only 1.6 USD is left as net profit.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2.1 USD for 1 USD of yearly profit. Over the last five years it was 13.3 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 8.0% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 86 USD
- Research and development 0.5 USD
- Sales and administration 9.1 USD
- Taxes and other 7.9 USD
- Net profit 1.6 USD
Net profit, industry median (Tobacco) 16 USD
Out of every 100 USD of revenue, 1.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Leaf Segment 100%
- Other Products and Services Segment 0.3%
By region
- Other Regions 34%
- CHINA 15%
- INDONESIA 12%
- UNITED STATES 12%
- BELGIUM 9.0%
- Other 18%
Leaf Segment brings in 100% of revenue.
Segments in detail